228 related articles for article (PubMed ID: 8480510)
1. Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains.
Morán MA; Mufson EJ; Gómez-Ramos P
Acta Neuropathol; 1993; 85(4):362-9. PubMed ID: 8480510
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains.
Morán MA; Mufson EJ; Gómez-Ramos P
Acta Neuropathol; 1994; 87(3):284-92. PubMed ID: 8009960
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural localization of butyrylcholinesterase in senile plaques in the brains of aged and Alzheimer disease patients.
Gómez-Ramos P; Morán MA
Mol Chem Neuropathol; 1997 Apr; 30(3):161-73. PubMed ID: 9165483
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro.
Cash MK; Rockwood K; Fisk JD; Darvesh S
Neurobiol Aging; 2021 Jul; 103():31-41. PubMed ID: 33789210
[TBL] [Abstract][Full Text] [Related]
6. Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid.
Geula C; Greenberg BD; Mesulam MM
Brain Res; 1994 May; 644(2):327-30. PubMed ID: 8050043
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
[TBL] [Abstract][Full Text] [Related]
8. Cholinesterases in the amyloid angiopathy of Alzheimer's disease.
Mesulam M; Carson K; Price B; Geula C
Ann Neurol; 1992 May; 31(5):565-9. PubMed ID: 1375822
[TBL] [Abstract][Full Text] [Related]
9. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
[TBL] [Abstract][Full Text] [Related]
10. Amyloid beta 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs.
Wisniewski T; Lalowski M; Bobik M; Russell M; Strosznajder J; Frangione B
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):575-80. PubMed ID: 8573095
[TBL] [Abstract][Full Text] [Related]
11. In silico modeling of the specific inhibitory potential of thiophene-2,3-dihydro-1,5-benzothiazepine against BChE in the formation of beta-amyloid plaques associated with Alzheimer's disease.
Ul-Haq Z; Khan W; Kalsoom S; Ansari FL
Theor Biol Med Model; 2010 Jun; 7():22. PubMed ID: 20550720
[TBL] [Abstract][Full Text] [Related]
12. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.
Geula C; Mesulam M
Brain Res; 1989 Sep; 498(1):185-9. PubMed ID: 2790472
[TBL] [Abstract][Full Text] [Related]
13. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
14. Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
Macdonald IR; Maxwell SP; Reid GA; Cash MK; DeBay DR; Darvesh S
J Alzheimers Dis; 2017; 58(2):491-505. PubMed ID: 28453492
[TBL] [Abstract][Full Text] [Related]
15. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
[TBL] [Abstract][Full Text] [Related]
16. Vascular variant of Alzheimer's disease characterized by severe plaque-like beta protein angiopathy.
Yamada M; Itoh Y; Suematsu N; Otomo E; Matsushita M
Dement Geriatr Cogn Disord; 1997; 8(3):163-8. PubMed ID: 9137894
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease.
Kalaria RN; Kroon SN; Grahovac I; Perry G
Neuroscience; 1992 Nov; 51(1):177-84. PubMed ID: 1465181
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.
Kumar R; Nordberg A; Darreh-Shori T
Brain; 2016 Jan; 139(Pt 1):174-92. PubMed ID: 26525916
[TBL] [Abstract][Full Text] [Related]
19. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
Dickson TC; Vickers JC
Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues.
Darvesh S; Reid GA; Martin E
Curr Alzheimer Res; 2010 Aug; 7(5):386-400. PubMed ID: 19939227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
